Amryt Pharmaceuticals PLC licenses gene therapy platform from … – Proactive Investors UK
Proactive Investors UK |
Amryt Pharmaceuticals PLC licenses gene therapy platform from …
Proactive Investors UK Amryt Pharma PLC (LON:AMYT) has licensed a non-viral gene therapy platform technology with potential applicability across a range of genetic diseases, including epidermolysis-bullosa (EB). The technology has been licensed from University College Dublin … Irish biopharma company and UCD to use gene therapy for rare skin disorder Rare disease firm Amryt reveals a "major" gene therapy tie-up as revenues rise Amryt reports strong 2017 as revenues rise to almost €13m |
